Palomino Laboratories Inc.
PALX· OTC
PALXPalomino Laboratories Inc.
Filed Nov 14, 2025 · 10-Q · 45 days after period end · 0001493152-25-023285
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Net Income | -$1.82M | -$6.33K | -$42.86K | -$4.25K |
| EPS Diluted | -$0.54 | $0.00 | -$0.01 | -$0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Palomino Laboratories Inc. · CIK 1938569 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Nov 14, 2025 · 45 d after period end
